248 related articles for article (PubMed ID: 22609245)
1. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
Otocka-Kmiecik A; Mikhailidis DP; Nicholls SJ; Davidson M; Rysz J; Banach M
Prog Lipid Res; 2012 Oct; 51(4):314-24. PubMed ID: 22609245
[TBL] [Abstract][Full Text] [Related]
2. 'Trig-onometry': non-high-density lipoprotein cholesterol as a therapeutic target in dyslipidaemia.
Jacobson TA
Int J Clin Pract; 2011 Jan; 65(1):82-101. PubMed ID: 21105969
[TBL] [Abstract][Full Text] [Related]
3. High-density lipoprotein subfractions--what the clinicians need to know.
Pirillo A; Norata GD; Catapano AL
Cardiology; 2013; 124(2):116-25. PubMed ID: 23428644
[TBL] [Abstract][Full Text] [Related]
4. Insights from recent meta-analysis: role of high-density lipoprotein cholesterol in reducing cardiovascular events and rates of atherosclerotic disease progression.
Negi S; Ballantyne CM
J Clin Lipidol; 2010; 4(5):365-70. PubMed ID: 21122680
[TBL] [Abstract][Full Text] [Related]
5. Should low high-density lipoprotein cholesterol (HDL-C) be treated?
Toth PP; Barylski M; Nikolic D; Rizzo M; Montalto G; Banach M
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):353-68. PubMed ID: 24840264
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for low high-density lipoproteins.
Hafiane A; Kellett S; Genest J
Curr Opin Endocrinol Diabetes Obes; 2014 Apr; 21(2):134-9. PubMed ID: 24535232
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidaemia and cardiovascular disease: low HDL-cholesterol as a therapeutic target in statin-treated patients: a role for nicotinic acid (niacin)?
Choudhury RP
Curr Opin Lipidol; 2010 Apr; 21(2):161-2. PubMed ID: 20616630
[No Abstract] [Full Text] [Related]
8. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
9. High-density lipoprotein particles, coronary heart disease, and niacin.
Asztalos BF
J Clin Lipidol; 2010; 4(5):405-10. PubMed ID: 21122684
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoproteins in the prevention of cardiovascular disease: changing the paradigm.
Tuteja S; Rader DJ
Clin Pharmacol Ther; 2014 Jul; 96(1):48-56. PubMed ID: 24713591
[TBL] [Abstract][Full Text] [Related]
11. [HDL and CETP in atherogenesis].
Pöss J; Böhm M; Laufs U
Dtsch Med Wochenschr; 2010 Feb; 135(5):188-92. PubMed ID: 20082258
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein and coronary heart disease: current and future therapies.
Natarajan P; Ray KK; Cannon CP
J Am Coll Cardiol; 2010 Mar; 55(13):1283-99. PubMed ID: 20338488
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefit from pharmacological elevation of high-density lipoprotein cholesterol: meta-regression analysis.
Hourcade-Potelleret F; Laporte S; Lehnert V; Delmar P; Benghozi R; Torriani U; Koch R; Mismetti P
Heart; 2015 Jun; 101(11):847-53. PubMed ID: 25872524
[TBL] [Abstract][Full Text] [Related]
14. The importance of recognizing and treating low levels of high-density lipoprotein cholesterol: a new era in atherosclerosis management.
Cardenas GA; Lavie CJ; Cardenas V; Milani RV; McCullough PA
Rev Cardiovasc Med; 2008; 9(4):239-58. PubMed ID: 19122582
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.
Mahdy Ali K; Wonnerth A; Huber K; Wojta J
Br J Pharmacol; 2012 Nov; 167(6):1177-94. PubMed ID: 22725625
[TBL] [Abstract][Full Text] [Related]
16. HDL-Targeting Therapeutics: Past, Present and Future.
Zakiev E; Feng M; Sukhorukov V; Kontush A
Curr Pharm Des; 2017; 23(8):1207-1215. PubMed ID: 27799042
[TBL] [Abstract][Full Text] [Related]
17. [New trends in lipidology: the increasing role of HDL-cholesterol].
Paragh G; Harangi M; László M
Orv Hetil; 2008 Jul; 149(30):1395-404. PubMed ID: 18621598
[TBL] [Abstract][Full Text] [Related]
18. Low high-density lipoprotein cholesterol and increased cardiovascular disease risk: an analysis of statin clinical trials.
Deedwania P; Singh V; Davidson MH
Am J Cardiol; 2009 Nov; 104(10 Suppl):3E-9E. PubMed ID: 19895938
[TBL] [Abstract][Full Text] [Related]
19. CardioPulse: is raising HDL a valid treatment target? : epidemiological studies show a relationship between high HDL and lower cardiovascular events but subsequent research casts doubt on treatment benefit.
Taylor J
Eur Heart J; 2013 Apr; 34(16):1174. PubMed ID: 23604754
[No Abstract] [Full Text] [Related]
20. Targeting cholesteryl ester transfer protein for the prevention and management of cardiovascular disease.
Barter PJ; Kastelein JJ
J Am Coll Cardiol; 2006 Feb; 47(3):492-9. PubMed ID: 16458126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
